Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : FNCTF save search
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Signs Exclusive Distribution Agreement with D9, LLC
Published: 2024-02-26 (Crawled : 14:00) - globenewswire.com
RWGI | $0.026 210K
|
n/a
|
| O: -30.91%
H: 123.68%
C: 106.58%
distribution agreement
Moleculin Announces Presentation of Positive Pharmacokinetics and Tissue-Organ Distribution Data Demonstrating High Antitumor Activity of Annamycin in Preclinical Cancer Models
Published: 2023-04-18 (Crawled : 18:00) - prnewswire.com
MBRX | News | $4.5235 2.9K
|
Health Technology
|
| O: 1.6%
H: 73.68%
C: -9.79%
distribution presentation positive cancer preclinical
Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its “Abuse and Misuse Deterrent Transdermal System” Application
Published: 2021-12-31 (Crawled : 15:00) - nutriband.com
NTRB | $4.04 11K
|
Manufacturing
|
| O: 80.31%
H: 72.76%
C: 42.98%
application patent system intel transdermal system
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034
Published: 2023-11-27 (Crawled : 12:00) - prnewswire.com
RDHL | $0.425 1.0% 150K
|
Health Technology
|
| O: 122.69%
H: 62.25%
C: 42.33%
talicia fda biopharma grant market
USPTO Grants New Patent to Evoke Pharma Covering the Usage of GIMOTI® To Treat Moderate to Severe Gastroparesis
Published: 2022-12-07 (Crawled : 14:00) - globenewswire.com
EVOK | $0.539 12.57% 470
|
Health Technology
|
| O: -3.03%
H: 54.17%
C: 40.97%
gimoti pharma patent grants
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Update and Begins Revenue Growth Curve
Published: 2024-02-20 (Crawled : 14:30) - globenewswire.com
RWGI | $0.026 210K
|
n/a
|
| O: -4.67%
H: 39.75%
C: 4.72%
revenue update growth
Greene Concepts Completes First Production Run of Happy Mellow Immune Support Beverage
Published: 2022-08-02 (Crawled : 19:00) - globenewswire.com
INKW | $0.0029 2.2M
|
Professional, Scientific, and T...
|
| O: 4.17%
H: 38.0%
C: 20.0%
Reed’s, Inc. Announces Transition from the Nasdaq Capital Market to the OTCQX and Close of $2.5 Million Bridge Financing
Published: 2023-02-14 (Crawled : 22:00) - globenewswire.com
REED | $3.24 0
|
Consumer Non-Durables
|
| O: -28.69%
H: 37.45%
C: 29.08%
nasdaq market
Harrow Announces U.S. FDA Approval of IHEEZO™ (Chloroprocaine Hydrochloride Ophthalmic Gel) 3% for Ocular Surface Anesthesia
Published: 2022-09-27 (Crawled : 00:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: -7.59%
H: 0.0%
C: 0.0%
HROW | $10.45 -3.69% 200K
|
Health Technology
|
| O: 1.31%
H: 36.19%
C: 26.2%
fda ocular approval
BioXcel Therapeutics Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI™ (dexmedetomidine) Sublingual Film
Published: 2023-10-04 (Crawled : 11:00) - globenewswire.com
BTAI | $2.66 4.31% 240K
|
Health Technology
|
| O: -2.56%
H: 35.96%
C: 16.23%
update expansion therapeutics
Lexaria's Technology Improves the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide in Human Pilot Study
Published: 2023-11-27 (Crawled : 20:00) - biospace.com/
LEXX | $2.25 9.9K
|
Health Technology
|
| O: 2.29%
H: 35.07%
C: 21.64%
drug technology pilot study
Tauriga Sciences Inc. Receives its 10,000th E-Commerce Order
Published: 2022-03-25 (Crawled : 17:00) - globenewswire.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: 5.15%
H: 0.0%
C: -3.73%
TAUG | $0.0001
|
|
| O: 2.7%
H: 34.21%
C: 23.68%
order
1.2M Shares of Nutriband Inc. to be Cancelled from Total Outstanding Shares Following Final Court Judgment in Favor of the Company
Published: 2022-07-26 (Crawled : 11:00) - nutriband.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: 0.38%
H: 0.0%
C: 0.0%
NTRB | $4.04 11K
|
Manufacturing
|
| O: 1.66%
H: 33.91%
C: 25.09%
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
Published: 2023-07-14 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.0354 320
|
Communications
|
| O: 0.97%
H: 0.0%
C: 0.0%
NTRB | $4.04 11K
|
Manufacturing
|
| O: 25.0%
H: 33.0%
C: 7.67%
fda platform submission
Emerging Markets Report: Apples to Apple Eaters
Published: 2022-04-14 (Crawled : 15:00) - globenewswire.com
SPYR | $0.0001 2M
|
Accommodation and Food Services
|
| O: -11.33%
H: 32.4%
C: 4.36%
Emerging Markets Report: Small Talk
Published: 2022-08-11 (Crawled : 13:00) - globenewswire.com
SPYR | $0.0001 2M
|
Accommodation and Food Services
|
| O: -14.94%
H: 32.2%
C: 12.2%
Tauriga Sciences Inc. Approved to Renew its Status as a Vendor to the National Association of College Stores
Published: 2021-12-01 (Crawled : 17:00) - globenewswire.com
TAUG | $0.0001
|
|
| O: -15.8%
H: 30.64%
C: 21.14%
store
RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results
Published: 2022-03-17 (Crawled : 13:00) - biospace.com/
RDHL | $0.425 1.0% 150K
|
Health Technology
|
| O: 0.0%
H: 30.05%
C: 24.59%
biopharma financial results report results tiona
ProQure and Identiv Partner to Launch Innovative NFC Type 2 Tags for Large-Scale NFC Deployments
Published: 2023-05-05 (Crawled : 10:00) - prnewswire.com
INVE 4 | $5.0 3.09% 44K
|
Electronic Technology
|
| O: 3.14%
H: 29.85%
C: 22.62%
Direct Digital Holdings Reports Q4 & Full-Year 2023 Results
Published: 2024-03-26 (Crawled : 20:00) - prnewswire.com
DRCT | $7.6 3.12% 37K
|
|
| O: -48.1%
H: 28.85%
C: 16.57%
FNCTF | News | $11.0354 320
|
Communications
|
| O: 0.82%
H: 0.3%
C: 0.3%
direct results
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.